1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Defining neuroblastoma : From origin to precision medicine
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
(
- Contribution to journal › Article
- 2019
-
Mark
Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region
(
- Contribution to journal › Article
-
Mark
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
(
- Contribution to journal › Article
- 2016
-
Mark
Development after pediatric brain tumor-a longitudinal study
(
- Contribution to journal › Article
- 2015
-
Mark
Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
(
- Contribution to journal › Article
-
Mark
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
(
- Contribution to journal › Article
-
Mark
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.
(
- Contribution to journal › Article
- 2014
-
Mark
Comparison of neuropsychological and brain imaging data in pediatric brain tumor patients surviving more than 10 years
2014) 16th International Symposium on Pediatric Neuro-Oncology In Neuro-Oncology 16(Suppl 1). p.99-104(
- Contribution to journal › Article
-
Mark
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.
(
- Contribution to journal › Article